ARCHIVES

In Congress: Could NCI Make Use Of Increase? Porter Asks; “We Can Handle It Well,” Klausner Replies

This article is from The Cancer Letter archive.

Vol. 24 No. 13 | April 3, 1998

Download PDF Visit The Full Archive

Related Articles

Study Supports Hypothesis On Mastectomy Timing

June 7, 1991

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

December 3, 2010

FDA News: Rep. Barton Expresses “Concern” About Plan To Merge Offices

May 22, 1998

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

May 30, 2008

In Brief: Blumberg, Comis, Skalka Named Fox Chase VPs; Howard Temin Appointed To NCAB

June 5, 1987

ACS President Lawrence Emphasizes Prevention Gains Since 1971

April 10, 1992